Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers
On this episode of Stock Movers: - Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news. - Arhaus (ARHS) is moving after Jefferies upgraded the furniture…
READ NEXT
More on the wire
FROM THE PUBLISHER
President Donald Trump returns to the General Assembly nearing the seven-month mark of a new war against Iran that he insists is necessary to address a nuclear threat posed by Iran.
FROM THE PUBLISHER
If the union collecting these workers' dues will not help them enter the future, they should reject the union.
FROM THE PUBLISHER
Actress Hayden Panettiere’s death has been ruled accidental from drugs including fentanyl, according to the Greenville County Coroner’s Office in South Carolina.